Last reviewed · How we verify
NCT05046262
Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study
Phase 3 trial testing Calcium chloride in Basal Cell Carcinoma in 25 participants. Status unknown.
22 February 2022
Quick facts
| Lead sponsor | Bispebjerg Hospital |
|---|---|
| Phase | Phase 3 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 8 January 2020 |
| Primary completion | 22 February 2022 |
| Estimated completion | 22 February 2022 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Calcium chloride (CALCIUM CHLORIDE) — full drug profile →
Conditions studied
- Basal Cell Carcinoma — all drugs for Basal Cell Carcinoma →
Sponsor
Bispebjerg Hospital
Who can join
18 and older, any sex, with Basal Cell Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
The Impact of Calcium Overload on Cellular Processes: Exploring Calcicoptosis and Its Therapeutic Potential in Cancer.
Gielecińska A, Kciuk M, Kontek R. · · 2024 · cited 23× · PMID 39769488 · DOI 10.3390/ijms252413727 -
Electroporation and Electrochemotherapy in Gynecological and Breast Cancer Treatment.
Łapińska Z, Szwedowicz U, Choromańska A, Saczko J. · · 2022 · cited 11× · PMID 35458673 · DOI 10.3390/molecules27082476 -
An Explorative Study on Calcium Electroporation for Low-risk Basal Cell Carcinoma.
Wiegell SR, Hendel K, Fuchs CSK, Gehl J, et al · · 2024 · cited 3× · PMID 38712969 · DOI 10.2340/actadv.v104.19678
Verify or expand the search:
- PubMed search for NCT05046262
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Calcium chloride
Trials testing the same drug.
- NCT05973747 — Pharmacokinetic Equivalence of Calcium Gluconate and Calcium Chloride in Parturients · EARLY_PHASE1 · completed
- NCT05027048 — Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery · Phase 3 · completed
Other recruiting trials for Basal Cell Carcinoma
Currently open trials in the same condition.
- NCT07182240 — Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Ba · NA · recruiting
- NCT07285044 — The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr · Phase 2 · recruiting
- NCT06600165 — Intraoperative Confocal Laser Scanning Microscopy With Use of AI for Optimized Surgical Excision of Basal Cell Carcinoma · recruiting
- NCT06384924 — Raman Spectroscopy and Skin Cancer · recruiting
- NCT06384053 — Skin Cancer and Hyperthermia and Radiotherapy · NA · recruiting
Other Bispebjerg Hospital trials
Trials by the same sponsor.
- NCT06872060 — The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance. · NA · not yet recruiting
- NCT07373587 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy · NA · not yet recruiting
- NCT07123558 — Anal Cancer Prevention in High-Risk Categories of Men Who Have Sex With Men · NA · not yet recruiting
- NCT07124338 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy, a Feasibili · NA · active not recruiting
- NCT07096648 — Alert Burden When Monitoring Patients at Home · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05046262 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bispebjerg Hospital
- Last refreshed: 16 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05046262.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing